Advertisement
Canada markets close in 2 hours 25 minutes

  • S&P/TSX

    21,986.00
    +100.62 (+0.46%)
     

  • S&P 500

    5,113.54
    +65.12 (+1.29%)
     

  • DOW

    38,326.35
    +240.55 (+0.63%)
     

  • CAD/USD

    0.7316
    -0.0007 (-0.10%)
     

  • CRUDE OIL

    83.83
    +0.26 (+0.31%)
     

  • Bitcoin CAD

    87,270.16
    -893.73 (-1.01%)
     

  • CMC Crypto 200

    1,325.33
    -71.20 (-5.10%)
     

  • GOLD FUTURES

    2,348.20
    +5.70 (+0.24%)
     

  • RUSSELL 2000

    2,004.77
    +23.65 (+1.19%)
     

  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     

  • NASDAQ

    15,975.65
    +363.89 (+2.33%)
     

  • VOLATILITY

    15.05
    -0.32 (-2.08%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Latest stubborn U.S. inflation reading will bring about more 'wait and see' from the Fed

Nasdaq Halts Moleculin Biotech Inc.

GlobeNewswire

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NDAQ) announced that the trading halt status in Moleculin Biotech Inc. (MBRX) was changed to "additional information requested" from the company. Trading in the company’s stock had been halted on May 4, 2020 at 9:25:06 Eastern Time at a last sale price of $1.07.

Trading will remain halted until Moleculin Biotech Inc.has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Bianca Fata
Bianca.Fata@nasdaq.com